Clinical features, treatment, and follow-up of OPPG and high-bone-mass disorders: LRP5 is a key regulator of bone mass
Osteoporosis International · 2024
DOI: 10.1007/s00198-024-07080-x ↗Kurz gefasst
Fallbericht in der Zeitschrift Osteoporosis International, 2024. Verfasst von Na Ren und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Osteoporosis and Bone Disease, Shanghai Clinical Research Center of Bone Disease, Sixth People's Hospital Affiliated to Shanghai Jiao T…. Hauptthemen laut MEDLINE: Low Density Lipoprotein Receptor-Related Protein-5, Bone Density, Bone Density Conservation Agents, Mutation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Key Technologies Research and Development Program, National Natural Science Foundation of China, Innovative Research Group Project of the National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Osteoporosis and Bone Disease, Shanghai Clinical Research Center of Bone Disease, Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Yishan Road 600, Shanghai, 200233,…
Förderung
- Key Technologies Research and Development Program
- National Natural Science Foundation of China
- Innovative Research Group Project of the National Natural Science Foundation of China
Zitieren
APA
Ren, N., Lv, S., Li, X., Shao, C., Wang, Z., Mei, Y., Yang, W., Fu, W., Hu, Y., Sha, L., Hu, W., Zhang, Z., & Wang, C. (2024). Clinical features, treatment, and follow-up of OPPG and high-bone-mass disorders: LRP5 is a key regulator of bone mass. Osteoporosis International. https://doi.org/10.1007/s00198-024-07080-x
Vancouver
Ren N, Lv S, Li X, Shao C, Wang Z, Mei Y, et al. Clinical features, treatment, and follow-up of OPPG and high-bone-mass disorders: LRP5 is a key regulator of bone mass. Osteoporosis International. 2024. doi:10.1007/s00198-024-07080-x
BibTeX
@article{Ren2024,
author = {Ren, Na and Lv, Shanshan and Li, Xiang and Shao, Chong and Wang, Ziyuan and Mei, Yazhao and Yang, Wendi and Fu, Wenzhen and Hu, Yunqiu and Sha, Ling and Hu, Weiwei and Zhang, Zhenlin and Wang, Chun},
title = {Clinical features, treatment, and follow-up of OPPG and high-bone-mass disorders: LRP5 is a key regulator of bone mass},
journal = {Osteoporosis International},
year = {2024},
doi = {10.1007/s00198-024-07080-x}
}
EUVIMED